What’s new in lung transplantation
by Professor John Dark (pictured) – In contrast with that other thoracic organ the heart, activity and optimism in the pulmonary field are both increasing. Contemporay outcomes for… read more.
by Professor John Dark (pictured) – In contrast with that other thoracic organ the heart, activity and optimism in the pulmonary field are both increasing. Contemporay outcomes for… read more.
FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
Researchers from the University of Southampton, in collaboration with psychologists from six other universities, have started a study to assess the impact of a new psychological therapy for… read more.
Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.
by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.
First study of its kind to focus on children. Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication… read more.
Up to one-third of cancer patients experience moderate to severe pain.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
Foreward by Dr Sanjay Popat (pictured). The 14th Annual Scientific Meeting of the IASLC has now closed. Held in Amsterdam at the beginning of July 2011, the annual… read more.
Nephrotoxicity as the Primary Driver of Failure – Fact or Fiction? – Dr Philip Halloran, Alberta Applied Genomics Center, Alberta, Canada. The calcineurin inhibitors (CNIs), ciclosporin and tacrolimus,… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.